0001144204-17-062200.txt : 20171204
0001144204-17-062200.hdr.sgml : 20171204
20171204160532
ACCESSION NUMBER: 0001144204-17-062200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171201
FILED AS OF DATE: 20171204
DATE AS OF CHANGE: 20171204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RINGO WILLIAM R
CENTRAL INDEX KEY: 0001238325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 171237083
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: (212) 554-4388
MAIL ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
tv480756_form4.xml
FORM 4
X0306
4
2017-12-01
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001238325
RINGO WILLIAM R
C/O ASSEMBLY BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 310
CARMEL
IN
46032
1
0
0
0
Common Stock
2017-12-01
4
M
0
1000
7.20
A
20465
D
Common Stock
2017-12-01
4
S
0
1000
49.37
D
19465
D
Stock Option (right to buy)
7.20
2017-12-01
4
M
0
1000
0
D
2024-07-10
Common Stock
1000
56000
D
The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This option, initially representing a right to purchase 64,000 shares, became exercisable in three equal installments on July 11, 2014; July 11, 2015; and July 11, 2016.
/s/ Elizabeth Lacy, as Attorney-in-Fact
2017-12-04